Association of Epigenetic Markers of Aging With Prevalent and Incident Type 2 Diabetes.

J Gerontol A Biol Sci Med Sci

Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Type 2 diabetes (T2D) is characterized by elevated levels of metabolic and inflammatory markers but less is known about other molecular alterations that occur with aging. We aimed to assess the associations of DNA methylation-based measures of aging (epigenetic aging) with prevalent and incident T2D in a large sample of middle-aged and older Australians.

Methods: We used data from 5 403 participants in the Melbourne Collaborative Cohort Study (mean age = 59 years). Five blood-based epigenetic aging measures: PCPhenoAge, PCGrimAge, DNAmFitAge, bAge, and DunedinPACE were calculated. T2D status was assessed at baseline (1990-1994, Ncases = 180) and 2 waves of follow-up (1995-1998, Ncases = 134; 2003-2007, Ncases = 244). Modified Poisson regression models were used to estimate risk ratios for the associations of epigenetic age with prevalent and incident T2D.

Results: A standard deviation increase in epigenetic age was associated with 1.11-fold (PCPhenoAge, 95%CI: 0.98-1.26) to 1.33-fold (bAge, 95%CI: 1.12-1.57) higher prevalence of T2D at baseline. Prospectively, DunedinPACE showed the strongest association with incident T2D at follow-up 2 (risk ratio = 1.22, 95%CI: 1.07-1.38). These estimates were slightly attenuated but consistent in sensitivity analyses reclassifying participants who reported being T2D-free but had high glucose concentrations (> 7 mmol/L for fasting glucose, > 11.1 mmol/L for nonfasting glucose). No evidence of increased epigenetic age was found for participants with pre-T2D (> 5.6 mmol/L for fasting glucose, > 7.8 mmol/L for nonfasting glucose). The positive associations between epigenetic age and fasting glucose levels appeared stronger in participants with T2D.

Conclusions: In middle-aged and older Australians, epigenetic age, in particular as assessed by bAge and DunedinPACE, was positively associated with prevalent and incident T2D. Our findings may have implications for understanding the etiology and management of T2D.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12198671PMC
http://dx.doi.org/10.1093/gerona/glaf085DOI Listing

Publication Analysis

Top Keywords

epigenetic age
20
prevalent incident
16
incident t2d
12
aging prevalent
8
type diabetes
8
epigenetic aging
8
middle-aged older
8
bage dunedinpace
8
associations epigenetic
8
mmol/l fasting
8

Similar Publications

Introduction: Epigenetic changes are important modulators of gene expression. The histone acetyltransferase gene non-derepressible 5 (Gcn5) is emerging as a pivotal epigenetic player in metabolism and cancer, yet its role in obesity and cardiovascular disease remains elusive.

Aims: To investigate Gcn5 role in obesity-related endothelial dysfunction.

View Article and Find Full Text PDF

It has been reported that DNA methylation in the epigenetic profile of the genes LEP and ADIPOQ is associated with obesity. To the best of our knowledge, there are no previous reports assessing the methylation of the LEP, LEPR, and ADIPOQ genes in subjects with metabolically healthy obesity (MHO). Therefore, the aim of this study was to determine the association between methylation of the LEP, LEPR, and ADIPOQ genes with the MHO phenotype.

View Article and Find Full Text PDF

Advanced maternal age increases the risk of pregnancy complications due, in part, to changes in the uterine environment. Here, we show that uterine aging in mice is associated with a progressive increase in transcriptional variation, accompanied by a notable accumulation of activating histone marks at multiple genomic loci. Importantly, the transcriptional signatures of uterine aging differ substantially from senescence markers associated with organismal aging.

View Article and Find Full Text PDF

Epigenetic Age Acceleration and Cardiometabolic Biomarkers in Response to Weight-Loss Dietary Interventions Among Obese Individuals: The MACRO Trial.

Aging Cell

September 2025

Department of Epidemiology, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.

Epigenetic clocks have emerged as promising biomarkers of aging, but their responsiveness to lifestyle interventions and relevance for short-term changes in cardiometabolic health remain uncertain. In this study, we examined the associations between three epigenetic aging measures (DunedinPACE, PCPhenoAge acceleration, and PCGrimAge acceleration) and a broad panel of cardiometabolic biomarkers in 144 obese participants from the MACRO trial, a 12-month weight-loss dietary intervention comparing low-carbohydrate and low-fat diets. At pre-intervention baseline, DunedinPACE was significantly associated with several cardiometabolic biomarkers (FDR [false discovery rate] < 0.

View Article and Find Full Text PDF

Cognitive disorders, a rapidly growing public health concern, can be prevented by a healthy diet. Several studies have shown that protein intake is a key modulator of cognitive function. The development of precision nutrition has allowed the study of specific amino acids within proteins, with many studies reporting that the level of methionine (Met) intake plays a central role in modulating cognitive function.

View Article and Find Full Text PDF